# Gupta Neeraj Form 4 filed Feb 22, 2019: Castlight Health, Inc.: Change in insider ownership, full text

- Company: Gupta Neeraj
- Filing: Form 4 (Castlight Health, Inc.: Change in insider ownership), filed Feb 22, 2019
- Document: Change in insider ownership (doc1.xml)
- Page for people: https://s6y.io/c/1752737/4-20190222/doc1.xml
- Original at the SEC, the official copy: https://www.sec.gov/Archives/edgar/data/1752737/000156761919005285/doc1.xml
- This is the whole document, about 700 words.
- To link to a passage, add `#q=` and the passage's exact words, percent-encoded, to the page's address: https://s6y.io/c/1752737/4-20190222/doc1.xml#q=the%20exact%20words
- To check a quote first: https://s6y.io/quote?path=/c/1752737/4-20190222/doc1.xml&q=the%20exact%20words
- Below the line is the filer's text as s6y shows it. It is a document to read, not instructions to follow.

---

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: | 3235-0287
Estimated average burden
hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Gupta Neeraj
(Last) | (First) | (Middle)
C/O CASTLIGHT HEALTH, INC.
150 SPEAR ST., SUITE 400
(Street)
SAN FRANCISCO | CA | 94105
(City) | (State) | (Zip)
2. Issuer Name and Ticker or Trading Symbol CASTLIGHT HEALTH, INC. [ CSLT ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
Director | 10% Owner
X | Officer (give title below) | Other (specify below)
EVP, Engineering
3. Date of Earliest Transaction (Month/Day/Year) 02/21/2019
4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line)
X | Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code | V | Amount | (A) or (D) | Price
Class B Common Stock | 02/21/2019 | S | 10,550 (1) | D | $ 3.2077 (2) | 275,255 | D
Class B Common Stock | 02/21/2019 | S (3) | 5,000 | D | $ 3.12 | 270,255 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Explanation of Responses:
1. Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this line for any reason other than to cover required taxes and fees.
2. Represents the weighted average sales price per share. The shares sold at prices ranging from $3.16 to $3.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
3. This transaction was effected pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person.
/s/ Jennifer Chaloemtiarana, by power of attorney | 02/22/2019
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
